Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
23.50
+0.12 (0.51%)
At close: Feb 3, 2026
SHE:300702 Market Cap
SHE:300702 has a market cap or net worth of 8.08 billion as of February 3, 2026. Its market cap has increased by 44.00% in one year.
Market Cap
8.08B
Enterprise Value
9.46B
Revenue
2.99B
Ranking
n/a
PE Ratio
42.48
Stock Price
23.50
Market Cap Chart
Since September 19, 2017, SHE:300702's market cap has increased from 3.87B to 8.08B, an increase of 108.72%. That is a compound annual growth rate of 9.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 8.04B | -0.93% |
| Dec 31, 2025 | 8.12B | 41.66% |
| Dec 31, 2024 | 5.73B | -24.15% |
| Dec 29, 2023 | 7.55B | -14.93% |
| Dec 30, 2022 | 8.88B | -47.22% |
| Dec 31, 2021 | 16.82B | -1.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wanbangde Pharmaceutical Holding Group | 9.56B |
| KPC Pharmaceuticals,Inc. | 9.45B |
| Frontier Biotechnologies | 9.14B |
| Zhejiang Xianju Pharmaceutical | 9.08B |
| Tianjin Ringpu Bio-Technology | 9.05B |
| Dezhan Healthcare Company | 9.04B |
| Harbin Pharmaceutical Group | 8.87B |
| Guilin Sanjin Pharmaceutical | 8.54B |